Lanreotide Acetate
Records for this ingredient, by country (identity only).
ATC H01CB03 · 3 markets · 25 records
AU 15 records · 9 shown of 9
- 150.3 mg per mL / per unit basis not statedinjectionLACREO lanreotide (as acetate) 120 mg/0.5 mL solution for injection prefilled syringeLANREOTIDE RBX lanreotide (as acetate) 120 mg/0.5 mL solution for injection prefilled syringe、LANREOTIDE SUN lanreotide (as acetate) 120 mg/0.5 mL solution for injection prefilled syringe
- 114.5 mg per mL / per unit basis not statedinjectionLACREO lanreotide (as acetate) 120 mg/0.5 mL solution for injection prefilled syringeLANREOTIDE RBX lanreotide (as acetate) 120 mg/0.5 mL solution for injection prefilled syringe、LANREOTIDE SUN lanreotide (as acetate) 120 mg/0.5 mL solution for injection prefilled syringe
- 78.8 mg per mL / per unit basis not statedinjectionLACREO lanreotide (as acetate) 120 mg/0.5 mL solution for injection prefilled syringeLANREOTIDE RBX lanreotide (as acetate) 120 mg/0.5 mL solution for injection prefilled syringe、LANREOTIDE SUN lanreotide (as acetate) 120 mg/0.5 mL solution for injection prefilled syringe
- 149.4 mg per mL / per unit basis not statedinjectionSOMATULINE AUTOGEL (lanreotide as acetate) 60mg solution for injection prefilled syringe
- 133.33 mg per mL / per unit basis not statedinjectionMYTOLAC lanreotide (as acetate) 120 mg solution for injection pre-filled syringe
- 113.6 mg per mL / per unit basis not statedinjectionSOMATULINE AUTOGEL (lanreotide as acetate) 60mg solution for injection prefilled syringe
- 100 mg per mL / per unit basis not statedinjectionMYTOLAC lanreotide (as acetate) 120 mg solution for injection pre-filled syringe
- 77.9 mg per mL / per unit basis not statedinjectionSOMATULINE AUTOGEL (lanreotide as acetate) 60mg solution for injection prefilled syringe
- 66.67 mg per mL / per unit basis not statedinjectionMYTOLAC lanreotide (as acetate) 120 mg solution for injection pre-filled syringe
FR 6 records · 3 shown of 3
- 120 mg per mL / per unit basis not statedinjection · extended-releaseMYRELEZ L.P. 120 mg, solution injectable à libération prolongée en seringue préremplieSOMATULINE L.P. 120 mg, solution injectable à libération prolongée en seringue préremplie
- 90 mg per mL / per unit basis not statedinjection · extended-releaseMYRELEZ L.P. 120 mg, solution injectable à libération prolongée en seringue préremplieSOMATULINE L.P. 120 mg, solution injectable à libération prolongée en seringue préremplie
- 60 mg per mL / per unit basis not statedinjection · extended-releaseMYRELEZ L.P. 120 mg, solution injectable à libération prolongée en seringue préremplieSOMATULINE L.P. 120 mg, solution injectable à libération prolongée en seringue préremplie
SG 3 records · 3 shown of 3
- 120 mg per mL / per unit basis not statedinjectionSomatuline Autogel Prolonged Release Solution for Injection in a Pre-filled Syringe 90 mg
- 90 mg per mL / per unit basis not statedinjectionSomatuline Autogel Prolonged Release Solution for Injection in a Pre-filled Syringe 90 mg
- 60 mg per mL / per unit basis not statedinjectionSomatuline Autogel Prolonged Release Solution for Injection in a Pre-filled Syringe 90 mg
Some strengths are recorded without a per mL / per unit basis. They are shown as recorded and are not compared with other markets.
The same ingredient can carry completely different
brand names in different countries, and the same name can point to a different ingredient.
Listed by country — not interchangeable.
Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.
A side-by-side table is offered only when this ingredient has records in many markets; otherwise this list is the whole picture.